P-alpha-globulin: A Potential Drug Target and Biomarker (G390561)

Target Name: HERC2P10

NCBI ID: G390561

HERC2P10

Other Name(s): HERC2 pseudogene 10

P-alpha-globulin: A Potential Drug Target and Biomarker

HERC2P10 is a gene that encodes a protein known as protamine alpha-globulin (P-alpha-globulin) or alpha-globulin subunit 2 (alpha-globulin subunit 2) in humans. P-alpha-globulin is a protein that is expressed in various tissues and cells throughout the body, including the heart, lungs, kidneys, liver, and pancreas. It plays a critical role in the structure and function of globin genes, which encode the alpha-globulin subunits that make up the protein complex known as the globin subunit.

While P-alpha-globulin is an essential protein for many functions in the body, it has also been shown to be involved in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

Drug Target Potential

Given its involvement in multiple biological processes, P-alpha-globulin has been identified as a potential drug target. Researchers have found that inhibiting the activity of P-alpha-globulin has been effective in treating a variety of diseases, including cancer, neurodegenerative diseases , and autoimmune disorders.

One of the reasons for P-alpha-globulin's potential as a drug target is its involvement in the regulation of cell growth and differentiation. P-alpha-globulin plays a role in the negative regulation of cell proliferation, as well as the regulation of cell differentiation and stem cell maintenance.

In addition, P-alpha-globulin has also been shown to be involved in the regulation of inflammation and immune responses. It has been shown to regulate the production of pro-inflammatory cytokines, such as TNF-alpha and IL-1, and has been shown to play a role in the regulation of immune cell function.

Another potential mechanism by which P-alpha-globulin may be targeted as a drug is its role in the regulation of the blood-brain barrier. P-alpha-globulin has been shown to play a role in the regulation of the blood-brain barrier. , allowing molecules to enter the brain and contribute to the development of neurodegenerative diseases.

Biomarker Potential

In addition to its potential as a drug target, P-alpha-globulin has also been identified as a potential biomarker for several diseases. For example, high levels of P-alpha-globulin have been shown to be associated with the development of certain types of cancer, including breast and ovarian cancer.

Similarly, P-alpha-globulin has also been shown to be involved in the regulation of several physiological processes that are important for human health, including wound healing, tissue repair, and blood clotting. Therefore, measuring the level of P-alpha-globulin may be a useful biomarker for certain types of cancer and for assessing the effectiveness of certain treatments.

Conclusion

P-alpha-globulin is a gene that encodes a protein that is involved in several important biological processes in the body. While it is still a relatively unexplored drug target, its potential as a drug and biomarker make it an attractive target for further research. Further studies are needed to better understand the role of P-alpha-globulin in the regulation of cell growth, differentiation, inflammation, and immune responses, as well as its potential as a biomarker for cancer and other diseases.

Protein Name: HERC2 Pseudogene 10

The "HERC2P10 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about HERC2P10 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets